About US

Driven by his passion for advancing the management of CNS disorders and spinal cord injuries, Dr. Bansal engaged in various research collaborations and visits to esteemed institutions, including:

– Miami Project to Cure Paralysis, USA
– Christopher Reeve-Irvine Research Center, California, USA
– Queen Elizabeth Spinal Trauma Centre, Glasgow, Scotland
– Neuroscience Center-Rutgers University, USA
– Egaz Monis Hospital, Lisbon, Portugal
– European Spinal Cord Research Institute, Brescia, Italy
– The Institute of Experimental Medicine Prague
– Beatson Institute, University of Glasgow
– Saint Gerkatuen Hospital, Berlin, Germany

Actively contributing to clinical research, Dr. Bansal focuses on utilizing autologous bone marrow, fat-derived adult Pluripotent VSEL, and MUSE stem cells in orthopedic and neurodegenerative diseases. He has pioneered several innovative protocols for treating various conditions, such as Optic Atrophy, CNS Injuries, Osteoarthritis Knee, Amylotrophic Lateral Sclerosis, Autism, Cerebral Palsy, and Heart Failure, with publications in national and international high-impact factor journals.

As a sought-after Guest Speaker, Dr. Bansal shares his expertise at conferences and symposiums in India and worldwide. Recently, he achieved early promising results with an ambitious multimodal approach to reverse brain death, a groundbreaking endeavor.

In the realm of medicine, innovation evolves continually. Regenerative medicine offers hope in challenging scenarios by harnessing the body’s own biological resources, such as fat, bone marrow, and blood, enriched with nutrients. This holistic approach respects human nature’s inherent ability to heal itself, presenting solutions for neurodegenerative disorders, autoimmune diseases, chronic illnesses, and stubborn wounds. Driven by the philosophy of utilizing our innate resources, regenerative medicine places the individual at the forefront, striving to heal the human body’s intricate machinery with technologies that continue to advance beyond our comprehension.

• Revita Life sciences offers stem cell application as clinical research as per FDA guidelines
• Patients are offered procedures on compassionate grounds on non commercial non profit basis
• Adjunctive treatment to boost healing like Hyperbaric Oxygen therapy, Electromagnetic pulse therapy Intravenous and Interstitial Low level Laser, Acupressure, Traditional Indian Ayurveda and Aggressive Rehabilitation is offered on chargeable basis.
• The principle is Autologous (patient’s own) with Practically No manipulation.
• Autologous (patient’s own) cells taken from bone marrow
• ”Prium Non Nocere”, which means “Not to harm”, as the treatment of any disease
  should not be more harmful than when leaving it untreated.
• No profit objective
• Unmanipulated
• Presence of platelet and growth factor rich plasma makes it more effective.
• The point of care-so no risk of contamination
• Adequate quantity of Cells per kg of body weight for clinical effect
• Polyclonal cell type in nature
• No risk of rejection
• Least side effects
• Route of administration individualised according to the disorder
• Scientifically monitored by a strict protocol.
• Ficoll* not used as per guidelines, these are done only as an experimental